CIK 0001684144 · Non-accelerated filer<br>Smaller reporting company
Zomedica Corp.
Sign in to watch- Ticker
- ZOMDF
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Alberta, Canada
- Entity type
- operating
- Phone
- (734) 369-2555
- Business address
- 1101 TECHNOLOGY DRIVE, SUITE 100, ANN ARBOR, MI, 48108
- Former names
- Zomedica Pharmaceuticals Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-17 | POWERS JOHNNY D Director | Purchase | +50,000 | $0.07 | $3K | 2,825,000 |
| 2025-03-17 | POWERS JOHNNY D Director | Purchase | +100,000 | $0.07 | $7K | 2,925,000 |
| 2025-03-17 | HEATON LARRY C II CEO | Purchase | +10,000 | $0.05 | $540 | 510,000 |
| 2025-03-17 | HEATON LARRY C II CEO | Purchase | +118,855 | $0.06 | $7K | 628,855 |
| 2025-03-17 | HEATON LARRY C II CEO | Purchase | +191,817 | $0.06 | $12K | 820,672 |
| 2025-03-17 | HEATON LARRY C II CEO | Purchase | +179,328 | $0.06 | $11K | 1,000,000 |
| 2025-03-17 | Blair Anthony K COO | Purchase | +500,000 | $0.06 | $30K | 900,000 |
| 2025-03-17 | Klass Russell Kevin Sr Vice President of Sales | Purchase | +699,980 | $0.07 | $49K | 3,200,030 |
| 2025-03-17 | Williams Rodney James Director | Purchase | +100,000 | $0.07 | $7K | 100,000 |
| 2025-02-21 | Klass Russell Kevin Sr Vice President of Sales | Grant or award · Option to buy common stock | +200,000 | 200,000 | ||
| 2025-01-01 | Jordan Scott Chief Financial Officer | Grant or award · Options to buy common stock | +5,000,000 | 5,000,000 | ||
| 2024-11-11 | POWERS JOHNNY D Director | Grant or award · Stock Appreciation Rights | +1,975,033 | 1,975,033 | ||
| 2024-11-11 | Whelan Sean Director | Grant or award · Stoock Appreciation Rights | +1,975,033 | 1,975,033 | ||
| 2024-11-11 | Rowe Jeffrey M Director | Grant or award · Stock Appreciation Rights | +2,126,959 | 2,126,959 | ||
| 2024-11-11 | POWERS JOHNNY D Director | Grant or award · Stock Appreciation Rights | +1,823,107 | 1,823,107 | ||
| 2024-11-11 | Nichols Pamela Director | Grant or award · Stock Appreciation Rights | +1,975,033 | 1,975,033 | ||
| 2024-11-11 | MACLEOD CHRISTOPHER ROSS Director | Grant or award · Stock Appreciation Rights | +1,823,107 | 1,823,107 | ||
| 2024-11-11 | Cohen Robert Director | Grant or award · Stock Appreciation Rights | +1,823,107 | 1,823,107 | ||
| 2024-11-11 | DeHaan-Fullerton Karen General Counsel/Corporate Secy | Grant or award · Options to Buy Common Stock | +500,000 | 500,000 | ||
| 2024-11-11 | Blair Anthony K COO | Grant or award · Options to Buy Common Stock | +400,000 | 400,000 |
Page 4 of 8 · 143 trades